Table 1 Demographic and clinical variables relative to the studied population of subjects. *significance (p < 0.01)
| Â | PIPO patients (No. 7) | Control patients (No. 7) | p-value |
|---|---|---|---|
Sex male n (%) | 5 (71%) | 2 (29%) | 0.1263 |
Age (years) Median (IQR) | 8.0 (14–5) | 10.0 (14–5) | 0.3057 |
Weight (Kg) Median (IQR) | 25 (35–15) | 42 (69–12.5) | 0.0728 |
PCR (mg/dl) Median (IQR) | 0.115 (0.53–0.01) | 0.05 (0.28–0.04) | 0.7668 |
Hb (g/dl) Median (IQR) | 12.75 (14 − 12.225) | 12.5 (14.1 − 12.2) | 0.8497 |
Ht (%) Median (IQR) | 39.5 (42–36) | 37 (41 − 36) | 0.3153 |
Ferritin (ng/ml) Median (IQR) | 32.5 (48–12) | 73 (90–51) | 0.0042* |
Calprotectin (mg/kg) Median (IQR) | 64 (72–51) | 76 (82–34) | 0.7928 |
Total proteins (g/dl) Median (IQR) | 6.5 (6.5–6.2) | 6.7 (6.9–6.1) | 0.5016 |
Albumin (g/dl) Median (IQR) | 4.3 (4.6–4) | 4.6 (4.7–4.3) | 0.1104 |